HCPLive

Nifedipine-Maintained Tocolysis No Benefit in Perinatal Outcomes

 
FRIDAY, Jan. 4 (HealthDay News) -- For women threatened with preterm labor, maintenance tocolysis with nifedipine is not associated with a significant reduction in adverse perinatal outcomes, according to a study published in the Jan. 1 issue of the Journal of the American Medical Association.

Carolien Roos, M.D., from the Radboud University Medical Center in Nijmegen, Netherlands, and colleagues conducted a randomized, double-blind, placebo-controlled study in 11 perinatal units in all tertiary centers in the Netherlands to examine whether maintenance tocolysis with nifedipine would reduce adverse perinatal outcome linked to premature birth. Women with threatened preterm labor between 26 and 32 weeks of gestation, who had not delivered after 48 hours of tocolysis and a completed course of corticosteroids, were randomized to oral nifedipine (201 women) or placebo (205 women) for 12 days. Surviving infants were followed for six months.

The researchers observed no significant between-group difference in adverse perinatal outcome (11.9 percent for nifedipine versus 13.7 percent for placebo; relative risk, 0.87; 95 percent confidence interval, 0.53 to 1.45).

"It seems likely that the absence of any effect is not due to ineffectiveness of nifedipine as a uterine relaxant," the authors write. "Apparently, symptomatic treatment of uterine contractions with any uterine relaxant is ineffective when used as maintenance therapy. The etiology of threatened preterm labor is multifaceted and includes subclinical intrauterine infection. Future research should be directed toward therapies tailored to the specific underlying causes of preterm labor."

One author disclosed a financial tie to CSL Behring, and one author reported provision of expert testimony to courts, payment for lectures, and private/unrelated stock/stock options.
 

Abstract
Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.
 

Most Popular

Recommended Reading

The fittest seniors are half as likely as others to suffer from heart failure, according to research published in the July 1 issue of JACC: Heart Failure.

Increased numbers of small cancers and precancerous lesions are found in geographical areas where more mammograms take place; however, the higher screening rates are not associated with reduced breast cancer mortality, according to a study published online July 6 in JAMA Internal Medicine.

For many cancers, mortality rates are declining and are expected to meet Healthy People 2020 (HP2020) targets, according to a study published online July 2 in the US Centers for Disease Control and Prevention's Preventing Chronic Disease.

Telemedicine monitoring is not associated with any significant difference in amputation or healing, but may be linked to increased mortality for patients with diabetic foot ulcers, according to a study published online June 26 in Diabetes Care.

$vAR$